Summary
Updated Aug 30, 2026
Robert Peter Kadlec files SEC Form 4 reports at MiNK Therapeutics, Inc. (INKT). 4 SEC Form 4 filings on record going back to 2024, most recently on 3 December 2025.
Recent Transactions
3Every recent SEC Form 4 transaction Robert Peter Kadlec has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Robert Peter Kadlec go back to 2024: 4 primary Form 4 filings, an average of 1.3 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Robert Peter Kadlec files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Barbara Ryan - $47K of INKT open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Robert Peter Kadlec?
Robert Peter Kadlec is a corporate insider of MiNK Therapeutics, Inc. (INKT). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Robert Peter Kadlec last file a Form 4?
The most recent primary Form 4 on record is dated 3 December 2025, one of 4 filings going back to 2024.
Where can I see all of Robert Peter Kadlec's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Robert Peter Kadlec and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial